drugset / Trial / NCT07423598
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics With AZD0780 Following Repeated Dose Administration in Healthy Adults With Elevated LDL-C Levels
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate pharmacodynamics (PD) of AZD0780 compared with placebo by assessment of low-density lipoprotein-cholesterol (LDL-C) levels following repeated oral dosing in healthy adults with elevated LDL-C levels.
Timeline
- Start
- 2026-02-24
- Primary completion
- 2026-06-29
- Completion
- 2026-06-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Laroprovstat | Small molecule | — | Oral |
Indications
No indication recorded.